Epithelioid Trophoblastic Tumour
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/131479 |
Resumo: | Funding: This article is based upon work from COST Action CA18117—European network for Gynaecological Rare Cancer research: From Concept to Cure (GYNOCARE), supported by COST (European Cooperation in Science and Technology). COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. www.cost.eu (accessed on 25 October 2021). |
id |
RCAP_d40ad75d9df9b5e8122f4b47d939b02e |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/131479 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Epithelioid Trophoblastic TumourA Case with Genetic Linkage to a Child Born over Seventeen Years Prior, Successfully Treated with Surgery and PembrolizumabEpithelioid trophoblastic tumourGestational trophoblastic tumourRare gynaecological tumourFunding: This article is based upon work from COST Action CA18117—European network for Gynaecological Rare Cancer research: From Concept to Cure (GYNOCARE), supported by COST (European Cooperation in Science and Technology). COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. www.cost.eu (accessed on 25 October 2021).Epithelioid trophoblastic tumours are rare neoplasms showing differentiation towards the chorion leave-type intermediate cytotrophoblast, with only a handful of cases being reported in the literature. These tumours are slow-growing and are typically confined to the uterus for extended periods of time. While the pathogenesis is unclear, they are thought to arise from a remnant intermediate trophoblast originating from prior normal pregnancies or, less frequently, gestational trophoblastic tumours. A protracted time period between the gestational event and tumour development is typical. This case describes a 49-year-old previously healthy female who presented with a completely asymptomatic uterine mass, discovered incidentally during a routine gynaecological assessment. The pathological analysis of the hysterectomy specimen confirmed an epithelioid trophoblastic tumour, involving the uterus and cervix. This is a rare gynaecological tumour. A comparative short tandem repeat analysis revealed genetic similarities to a previous healthy gestation seventeen years prior. She was successful treated with adjuvant pembrolizumab, with no evidence of disease recurrence to date.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNPisani, DavidCalleja-Agius, JeanDi Fiore, RiccardoO'Leary, John JBeirne, James PO'Toole, Sharon AFelix, AnaSaid-Huntingford, Ian2022-01-25T03:30:21Z2021-12-132021-12-13T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article10application/pdfhttp://hdl.handle.net/10362/131479eng1198-0052PURE: 36219532https://doi.org/10.3390/curroncol28060446info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:10:03Zoai:run.unl.pt:10362/131479Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:47:04.805256Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Epithelioid Trophoblastic Tumour A Case with Genetic Linkage to a Child Born over Seventeen Years Prior, Successfully Treated with Surgery and Pembrolizumab |
title |
Epithelioid Trophoblastic Tumour |
spellingShingle |
Epithelioid Trophoblastic Tumour Pisani, David Epithelioid trophoblastic tumour Gestational trophoblastic tumour Rare gynaecological tumour |
title_short |
Epithelioid Trophoblastic Tumour |
title_full |
Epithelioid Trophoblastic Tumour |
title_fullStr |
Epithelioid Trophoblastic Tumour |
title_full_unstemmed |
Epithelioid Trophoblastic Tumour |
title_sort |
Epithelioid Trophoblastic Tumour |
author |
Pisani, David |
author_facet |
Pisani, David Calleja-Agius, Jean Di Fiore, Riccardo O'Leary, John J Beirne, James P O'Toole, Sharon A Felix, Ana Said-Huntingford, Ian |
author_role |
author |
author2 |
Calleja-Agius, Jean Di Fiore, Riccardo O'Leary, John J Beirne, James P O'Toole, Sharon A Felix, Ana Said-Huntingford, Ian |
author2_role |
author author author author author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Pisani, David Calleja-Agius, Jean Di Fiore, Riccardo O'Leary, John J Beirne, James P O'Toole, Sharon A Felix, Ana Said-Huntingford, Ian |
dc.subject.por.fl_str_mv |
Epithelioid trophoblastic tumour Gestational trophoblastic tumour Rare gynaecological tumour |
topic |
Epithelioid trophoblastic tumour Gestational trophoblastic tumour Rare gynaecological tumour |
description |
Funding: This article is based upon work from COST Action CA18117—European network for Gynaecological Rare Cancer research: From Concept to Cure (GYNOCARE), supported by COST (European Cooperation in Science and Technology). COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. www.cost.eu (accessed on 25 October 2021). |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-12-13 2021-12-13T00:00:00Z 2022-01-25T03:30:21Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/131479 |
url |
http://hdl.handle.net/10362/131479 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1198-0052 PURE: 36219532 https://doi.org/10.3390/curroncol28060446 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
10 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138073951338496 |